Clinical Trials Logo

Filter by:
NCT ID: NCT05970120 Completed - Clinical trials for Ventricular Tachycardia

A Study of Intracardiac Ultrasound With the NUVISION NAV Ultrasound Catheter

Start date: September 5, 2023
Phase: N/A
Study type: Interventional

The purpose of this study is to assess the performance and safety of using the investigational catheter.

NCT ID: NCT05970029 Recruiting - Acute Pain Clinical Trials

Influence of the Communication Between Nursing Staff and Patients on the Analgesic Response Following Caesarean Section

Start date: June 1, 2023
Phase: N/A
Study type: Interventional

Effective management of postoperative pain is a priority for women undergoing cesarean delivery. Despite availability of modern analgesics, postoperative pain management remains a challenge. One opportunity to enhance the analgesic effect of the pharmacological treatments given to people suffering from pain (and not just pain) is through increasing the expectations for pain relief following treatment. Although much knowledge has been accumulated about the significant effect of expectations on pain, virtually all evidence are based on experimental studies carried out in laboratory settings, and there is a need to investigate how this knowledge could translated into improved clinical care. The aim of the current study is to examine whether the communication style between the nursing staff and the patient during analgesic administration will affect the results of pain relief treatment in the mother-newborn ward after cesarean section. As another goal, the study will examine whether relevant patient's characteristics will predict the effectiveness of the treatment.

NCT ID: NCT05969353 Recruiting - Clinical trials for Assessing the Effectiveness of BFA as a Non-pharmacologic Pain Management Intervention: A Randomised Sham Controlled Study

Assessing the Effectiveness of BFA as a Non-pharmacologic Pain Management Intervention: A Randomised Sham Controlled Study

Start date: July 23, 2023
Phase: N/A
Study type: Interventional

This is a randomized sham controlled study that will include patients hospitalized in the internal medicine department and the orthopedics department at Bnei Zion Hospital presenting with pain from various sources with an NRS level equal to or above 4.

NCT ID: NCT05967962 Recruiting - Clinical trials for Posttraumatic Stress Disorder

Sensory Modulation Dysfunction and Posttraumatic Stress Disorder

Start date: July 30, 2023
Phase: N/A
Study type: Interventional

To explore the role of sensory modulation dysfunction (SMD) (i.e., a neurodevelopmental state altering the sensory perception, severely interfering with daily function) as a risk factor for posttraumatic stress disorder (PTSD), its co-occurring pain, and impeded cognitive functions, following exposure to combat trauma.

NCT ID: NCT05965167 Active, not recruiting - Hypoparathyroidism Clinical Trials

Assess Safety and Compare PK of New Oral hPTH(1-34) Tablet Formulations vs. EBP05 Tablets and Subcutaneous Forteo

Start date: May 11, 2023
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to characterize and compare the pharmacokinetics of hPTH(1 34) after treatment with a modified oral formulation (EBP11 and EBP22) versus two dose levels of Entera Bio's extensively studied oral EBP05 1.5 mg and 2.5 mg as well as the commercial Forteo 0.02 mg subcutaneous injection.

NCT ID: NCT05963711 Recruiting - Clinical trials for Microbial Colonization

The Genital Microbiome of Male Partners of Women With Recurrent BV Undergoing Vaginal Microbiome Transplantation

Start date: October 17, 2022
Phase: N/A
Study type: Interventional

There is strong observational evidence that sexual activity plays a key role in Bacterial Vaginosis (BV) acquisition and recurrence. Microbiological data support the contribution of sexual transmission to the pathogenesis of BV through the exchange of BV-associated bacteria (BVAB) between sexual partners. Although BV epidemiology strongly suggests sexual transmission, treatment of sexual partners is not recommended, based on prior treatment studies of male partners of women with recurrent BV, which showed no benefit with male treatment. Nevertheless, male condom use is highly protective against recurrent BV. This study aims to evaluate the male-partner's genital microbiome as a potential source of BV-recurrence in women undergoing vaginal microbiota transplantation (NCT04517487), and whether disinfection can eliminate BV-associated penile microbiome.

NCT ID: NCT05961241 Completed - Clinical trials for Urinary Stress Incontinence

Pelvic Floor Muscle Function Among Running Women

Start date: January 1, 2023
Phase: N/A
Study type: Interventional

This study will examine pelvic floor muscles function amongst women who run on a regular basis compared to controls. Women who do not run, will begin running protocol, and second evaluation will be performed following 2 months of training. Urinary incontinence will also be assessed.

NCT ID: NCT05961228 Recruiting - Clinical trials for Scoliosis Idiopathic

Back Muscle Function in Adolescents With Idiopathic Scoliosis

Start date: July 10, 2023
Phase: N/A
Study type: Interventional

The function and asymmetry of back muscles will be examined in different positions and with specific spinal corrections based on scoliosis pattern and according to the "Schroth method" in adolescents with idiopathic scoliosis.

NCT ID: NCT05959603 Recruiting - Infection Clinical Trials

Intra-wound Vancomycin Powder for Prevention of Surgical Site Infection Following Spinal Surgery

Start date: May 31, 2020
Phase: Phase 3
Study type: Interventional

Cefazolin is given routinely pre and intraoperatively for patients undergoing spinal surgery to reduce the rate of infection. Intra-wound admission of Vancomycin powder has been suggested to reduce wound infection rates. Therefore, this study aims to compare the rate of wound-related complications between patients receiving standard treatment compared to patients receiving an addition of topical Vancomycin and to identify the optimal Vancomycin dosage. All groups will receive the recommended regimen of routine IV antibiotic prophylaxis.

NCT ID: NCT05959278 Recruiting - Vestibular Disorder Clinical Trials

Pilot Feasibility of App-supported Vestibular Rehabilitation

Start date: July 16, 2023
Phase: N/A
Study type: Interventional

The primary goal of the study is to examine the feasibility of accompanying vestibular practice supported by a phone app for vestibular rehabilitation. Feasibility will be established using the following parameters: (1) the User Satisfaction Evaluation Questionnaire (USEQ) (2) a custom-made questionnaire to collect feedback from participants, and (3) compliance measurements derived from app usage. The secondary goal of the study is to examine the effect of practice supported by the app on balance and anxiety indices. These will be measured using the following parameters: (1) Instrumented Timed Up and Go Test (iTUG), (2) Dizziness Handicap Inventory (DHI), (3) State-Trait Anxiety Inventory (STAI). The third goal is to assess the correlation between balance function (iTUG) and anxiety (STAI). A randomized crossover pilot study will be conducted with 24 participants. During the study, each group will undergo two and a half weeks of conventional vestibular rehabilitation and two and a half weeks of app-supported vestibular rehabilitation. Measurement sessions will be conducted at three-time points: upon enrollment in the study (T0), after two and a half weeks (T1), and at the end of the study (T2).